Posttransplant Lymphoproliferative Disease after Lung Transplantation

Posttransplant lymphoproliferative disease (PTLD) after lung transplantation occurs due to immunosuppressant therapy which limits antiviral host immunity and permits Epstein-Barr viral (EBV) replication and transformation of B cells. Mechanistically, EBV survives due to latency, escape from cytotoxi...

Descripción completa

Detalles Bibliográficos
Autor principal: Isabel P. Neuringer
Formato: Artículo
Lenguaje:English
Publicado: Hindawi Limited 2013-01-01
Colección:Clinical and Developmental Immunology
Acceso en línea:http://dx.doi.org/10.1155/2013/430209